Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization - Total: 2015-2021

Historic Depreciation & Amortization - Total for AC Immune (ACIU) over the last 7 years, with Dec 2021 value amounting to $557,023.

  • AC Immune's Depreciation & Amortization - Total rose 73.93% to $341,270 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 55.23%. This contributed to the annual value of $557,023 for FY2021, which is 16.57% up from last year.
  • AC Immune's Depreciation & Amortization - Total amounted to $557,023 in FY2021, which was up 16.57% from $477,859 recorded in FY2020.
  • Over the past 5 years, AC Immune's Depreciation & Amortization - Total peaked at $557,023 during FY2021, and registered a low of -$981,803 during FY2018.
  • Over the past 3 years, AC Immune's median Depreciation & Amortization - Total value was $477,859 (recorded in 2020), while the average stood at $486,414.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first tumbled by 111.46% in 2017, then spiked by 143.22% in 2019.
  • Yearly analysis of 5 years shows AC Immune's Depreciation & Amortization - Total stood at -$587,876 in 2017, then plummeted by 67.01% to -$981,803 in 2018, then skyrocketed by 143.22% to $424,361 in 2019, then rose by 12.61% to $477,859 in 2020, then rose by 16.57% to $557,023 in 2021.